In the News

ADA position statement updates recommendations for diabetic retinopathy

The position statement, an update of one from 2002, outlines the stages of diabetic retinopathy and highlights recommendations on optimal blood glycemic control and lowering blood pressure.

Dapagliflozin associated with lower risk for all-cause mortality in type 2 diabetes regardless of CVD risk, study finds

The population-based retrospective cohort study included 22,124 type 2 diabetes patients from a British national primary care database, 4,444 of whom had taken dapagliflozin.

Higher prevalence of complications in young adults diagnosed with type 2 vs. type 1 diabetes

Compared to those with type 1 diabetes, participants with type 2 had a significantly higher age-adjusted prevalence of diabetic kidney disease, retinopathy, peripheral, arterial stiffness, and hypertension by age 21.

MKSAP quiz: Diabetes and atrial fibrillation

This month's quiz asks readers to evaluate a man with type 2 diabetes who recently had a bare metal stent placed.

Spotlight on geriatrics

Older patients with diabetes were the focus of several recent studies, including one that looked at associations between glycemic control and mortality and two that compared second-line medication options.

Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes

Having diabetes was associated with higher risk of a major cardiovascular event after implementation of a drug-eluting stent, according to a systematic review.